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Identity 
Other names: RPF-1 (Retina-derived POU-domain 
factor-1) 






POU6F2, previously named RPF-1 was isolated from a 
retina cDNA library. 
Description 
Thirteen exons, including 4 alternative exons 1,  
encompassing 458 Kb of genomic DNA (exons 1D to 
10). 
Transcription 
Representative mRNA: U91935 2159 bases. 
Alternative splicings: four alternative exons 1; variable 
skipping of exon 6; variable skipping of both exons 8 
and 9; +/- 36 aminoacids at the 5' end of exon 10. 
Protein 
Description 
POU6F2 is a member of a gene family whose products 
are characterized by the presence of a bipartite DNA-
binding domain, consisting of a POU-specific domain 
and a POU heterodomain, separated by a variable 
polylinker.  
 
Modified from http://genome.ucsc.edu/. Exons 1D to 10 of the gene are indicated by the vertical bars. 
 
Modified from: http://www.ebi.ac.uk/ 
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Both subdomains contain helix-turn-helix motifs that 
directly associate with the two components of bipart te 
DNA-binding sites. In addition, the POU6F2 protein 
contains a poly-glutamine (poly-Q) domain. Glutamine 
repeats are evolutionary conserved domains that may 
act as polar zippers by joining proteins bound to 
separate DNA segments and thus regulating their 
activity. POU domain family members are 
transcriptional regulators, many of which show highly 
restricted patterns of expression and are known to 
control cell type-specific differentiation pathways. 
POU6F2 encodes a deduced 648-amino acid protein. 
Alternative splicing potentially generates 24 distinc  
mRNA isoforms coding for proteins with different 
DNA-binding activity. The most abundant POU6F2 
isoforms in human retina have an insertion of an 
evolutionarily conserved 36-amino acid peptide intothe 
DNA recognition helix of the POU-specific domain. I 
vitro, the POU domain of POU6F2 lacking the insert 
binds to a consensus binding site for the product of 
another gene of the POU family, OCT1, whereas the 
alternatively spliced POU domain does not. 
Expression 
Immunohistochemical and ribonuclease protection 
assays showed that in adult mouse Pou6f2 is expressed 
within the central nervous system, where its expression 
is restricted to the medial habenula, to a dispersed 
population of neurons in the dorsal hypothalamus, and 
to subsets of ganglion and amacrine cells in the retina. 
In mouse embryo, Pou6f2 expression was detected 
during the earliest stages of retinal differentiation 
where it appears to be involved in the initial step of 
amacrine and ganglion cell commitment. RT-PCR 
analysis of the mouse Pou6f2 gene revealed expression 
in kidney, adrenal gland, heart, stomach, muscle, and 
eye, but not in lung or skin, of mouse fetuses at 
embryonic day (E) 18, and in kidney, heart, muscle, 




POU-domain family transcription factor (presumptive). 
Homology 
Other POU-domain family genes. 
Mutations 
Note 
The POU6F2 gene is located within an interval on 
chromosome 7p14 where loss of heterozygosity (LOH) 
was detected in a fraction of Wilms tumors (WTs), a 
kidney malignancy of childhood characterized by 
highly heterogeneous genetic alterations. By 
sequencing the POU6F2 gene in 12 WTs showing LOH  
on chromosome 7p14, 2 germline mutations of possible 
pathogenic significance were identified. The finding of 
the expression of the POU6F2 mouse homolog in both 
fetal and adult kidney, together with the demonstration 
of mutations in WT patients, suggest that the gene is a 
tumor suppressor and is involved in hereditary 
predisposition to WT. 
Germinal 
In a patient with WT and LOH at chromosome 7p14, a 
germline 552G-T transversion in exon 5 of the 
POU6F2 gene, resulting in a gln184-to-his (Q184H) 
substitution in a glutamine repeat domain, was 
identified. The patient showed loss of the 
constitutionally wildtype allele in tumor DNA. Neither 
the mother nor the father carried this mutation. Marker 
studies indicated that the deletion in tumor DNA was of 
maternal origin, suggesting that the identified base 
change most likely occurred as a de novo germline 
point mutation on the paternal chromosome. In a 
patient with WT showing LOH at chromosome 7p14, a 
germline C-to-G transversion in the untranslated 
portion of the alternatively spliced exon 1C of the 
POU6F2 gene was identified. The mutation was 
inherited from the unaffected mother. 
Implicated in 
Wilms tumor, or nephroblastoma 
Prognosis 
Good with treatment according to National Wilms 
Tumor Study Group (NWTSG) or International Society 
of Paediatric Oncology (SIOP) or Associazione Italiana 
Ematologia Oncologia Pediatrica (AIEOP). 
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